David BALAYSSAC
UMR 1107 INSER/UCA Neuro-Dol
Facultés de Médecine et Pharmacie
Place Henri Dunant
63001 Clermont-Ferrand
FRANCE
Pr. David BALAYSSAC
Professor
TEAM 1 (J. BUSSEROLLES), TEAM 1 patient axis
david.balayssac@-Code to remove to avoid SPAM-uca.fr
Journal articles
2023
- ref_biblio
- David Balayssac, Julie Durif, Céline Lambert, Cristelle Dalbos, Eric Chapuy, et al.. Exploring Serum Biomarkers for Neuropathic Pain in Rat Models of Chemotherapy-Induced Peripheral Neuropathy: A Comparative Pilot Study with Oxaliplatin, Paclitaxel, Bortezomib, and Vincristine. Toxics, 2023, 11 (12), pp.1004. ⟨10.3390/toxics11121004⟩. ⟨hal-04332718⟩
- Accès au texte intégral et bibtex
- ref_biblio
- David Balayssac, Bruno Pereira, Juliette Desmard, Hugo Viers, Carole Barillon, et al.. Satisfaction of Cancer Patients Treated with Oral Anticancer Medications regarding Dispensing by Community Pharmacists: A Cross-Sectional Study. European Journal of Cancer Care, 2023, 2023, pp.1 - 9. ⟨10.1155/2023/7746349⟩. ⟨hal-04213488⟩
- Accès au texte intégral et bibtex
- ref_biblio
- David Balayssac, Jérôme Busserolles, Catherine Broto, Cristelle Dalbos, Laetitia Prival, et al.. Neurofilament light chain in plasma as a sensitive diagnostic biomarker of peripheral neurotoxicity: In Vivo mouse studies with oxaliplatin and paclitaxel - NeuroDeRisk project. Biomedicine and Pharmacotherapy, 2023, 167, pp.115535. ⟨10.1016/j.biopha.2023.115535⟩. ⟨hal-04213471⟩
- Accès au texte intégral et bibtex
- ref_biblio
- Julie Maraud, Sabrina Bedhomme, Bruno Pereira, Sophie Trévis, Marine Jary, et al.. Self-Medication during and after Cancer: A French Nation-Wide Cross-Sectional Study. Cancers, 2023, 15 (12), pp.3190. ⟨10.3390/cancers15123190⟩. ⟨hal-04213499⟩
- Accès au texte intégral et bibtex
- ref_biblio
- Edouard Montigné, David Balayssac. Exploring Cholinergic Compounds for Peripheral Neuropathic Pain Management: A Comprehensive Scoping Review of Rodent Model Studies. Pharmaceuticals, 2023, 16 (10), pp.1363. ⟨10.3390/ph16101363⟩. ⟨hal-04285363⟩
- Accès au texte intégral et bibtex
2021
- ref_biblio
- David Balayssac, Bruno Pereira, Pierre Cuq, Juliette Douris, Luc Ferrari, et al.. Perception of pharmacy students toward opioid-related disorders and roles of community pharmacists: A French nationwide cross-sectional study. Substance Abuse, 2021, 42 (4), pp.706-715. ⟨10.1080/08897077.2020.1850607⟩. ⟨hal-03077594⟩
- Accès au bibtex
- ref_biblio
- Frédéric Dutheil, Lenise M. Parreira, Julia Eismann, François-Xavier Lesage, David Balayssac, et al.. Burnout in french general practitioners: a nationwide prospective study. International Journal of Environmental Research and Public Health, 2021, 18 (22), pp.1-16. ⟨10.3390/ijerph182212044⟩. ⟨hal-03483172⟩
- Accès au texte intégral et bibtex
2020
- ref_biblio
- Mélissa Cuménal, Marie Selvy, Nicolas Kerckhove, Célian Bertin, Margaux Morez, et al.. The Safety of Medications used to Treat Peripheral Neuropathic Pain, Part 2 (Opioids, Cannabinoids and Other Drugs): review of Double-Blind, Placebo-Controlled, Randomized Clinical Trials. Expert Opinion on Drug Safety, 2020, pp.1-18. ⟨10.1080/14740338.2021.1842871⟩. ⟨hal-02997543⟩
- Accès au texte intégral et bibtex
- ref_biblio
- Marie Selvy, Mélissa Cuménal, Nicolas Kerckhove, Christine Courteix, Jérôme Busserolles, et al.. The safety of medications used to treat peripheral neuropathic pain, part 1 (antidepressants and antiepileptics): review of double-blind, placebo-controlled, randomized clinical trials. Expert Opinion on Drug Safety, 2020, 19 (6), pp.707-733. ⟨10.1080/14740338.2020.1764934⟩. ⟨hal-02997564⟩
- Accès au texte intégral et bibtex
- ref_biblio
- Marie Selvy, Bruno Pereira, Nicolas Kerckhove, Coralie Gonneau, Gabrielle Feydel, et al.. Long-Term Prevalence of Sensory Chemotherapy-Induced Peripheral Neuropathy for 5 Years after Adjuvant FOLFOX Chemotherapy to Treat Colorectal Cancer: A Multicenter Cross-Sectional Study. Journal of Clinical Medicine, 2020, 9 (8), pp.2400. ⟨10.3390/jcm9082400⟩. ⟨hal-02997588⟩
- Accès au texte intégral et bibtex
2019
- ref_biblio
- Damien Bouvier, David Balayssac, Julie Durif, Charline Mourgues, Catherine Sarret, et al.. Assessment of the advantage of the serum S100B protein biomonitoring in the management of paediatric mild traumatic brain injury—PROS100B: protocol of a multicentre unblinded stepped wedge cluster randomised trial. BMJ Open, 2019, 9 (5), pp.e027365. ⟨10.1136/bmjopen-2018-027365⟩. ⟨hal-02237348⟩
- Accès au texte intégral et bibtex
- ref_biblio
- Nicolas Kerckhove, Jérôme Busserolles, Trevor Stanbury, Bruno Pereira, Valérie Plence, et al.. Effectiveness assessment of riluzole in the prevention of oxaliplatin-induced peripheral neuropathy: RILUZOX-01: protocol of a randomised, parallel, controlled, double-blind and multicentre study by the UNICANCER-AFSOS Supportive Care intergroup. BMJ Open, 2019, 9 (6), pp.e027770. ⟨10.1136/bmjopen-2018-027770⟩. ⟨hal-02325112⟩
- Accès au texte intégral et bibtex
- ref_biblio
- Catherine Laporte, Céline Lambert, Bruno Pereira, Olivier Blanc, Nicolas Authier, et al.. Cannabis users: Screen systematically, treat individually. A descriptive study of participants in a randomized trial in primary care. PLoS ONE, 2019, 14 (12), pp.e0224867. ⟨10.1371/journal.pone.0224867⟩. ⟨inserm-02406964⟩
- Accès au texte intégral et bibtex
2018
- ref_biblio
- David Balayssac, Bruno Pereira, Maxime Darfeuille, Pierre Cuq, Laurent Vernhet, et al.. Use of Psychotropic Medications and Illegal Drugs, and Related Consequences Among French Pharmacy Students – SCEP Study: A Nationwide Cross-Sectional Study. Frontiers in Pharmacology, 2018, 9, pp.725. ⟨10.3389/fphar.2018.00725⟩. ⟨hal-01858850⟩
- Accès au texte intégral et bibtex
- ref_biblio
- Laura Poupon, Sylvain Lamoine, Vanessa Pereira, David Barriere, Stéphane Lolignier, et al.. Targeting the TREK-1 potassium channel via riluzole to eliminate the neuropathic and depressive-like effects of oxaliplatin. Neuropharmacology, 2018, 140, pp.43-61. ⟨10.1016/j.neuropharm.2018.07.026⟩. ⟨hal-02065469⟩
- Accès au texte intégral et bibtex
2017
- ref_biblio
- David Balayssac, Bruno Pereira, Julie Virot, Aurore Collin, David Alapini, et al.. Burnout, associated comorbidities and coping strategies in French community pharmacies—BOP study: A nationwide cross-sectional study. PLoS ONE, 2017, 12 (8), pp.e0182956. ⟨10.1371/journal.pone.0182956⟩. ⟨hal-01662459⟩
- Accès au texte intégral et bibtex
- ref_biblio
- David Balayssac, Bruno Pereira, Julie Virot, Celine Lambert, Aurore Collin, et al.. Work-related stress, associated comorbidities and stress causes in French community pharmacies: a nationwide cross-sectional study. PeerJ, 2017, 5, pp.e3973. ⟨10.7717/peerj.3973⟩. ⟨hal-01662581⟩
- Accès au texte intégral et bibtex
- ref_biblio
- David Balayssac, Bruno Pereira, Jean-Etienne Bazin, Bertrand Le Roy, Denis Pezet, et al.. Erratum to: Warmed and humidified carbon dioxide for abdominal laparoscopic surgery: meta-analysis of the current literature. Surgical Endoscopy, 2017, 31 (1), pp.13 - 16. ⟨10.1007/s00464-016-5335-6⟩. ⟨hal-01682151⟩
- Accès au bibtex
- ref_biblio
- Nicolas Kerckhove, Aurore Collin, Sakahlé Condé, Carine Chaleteix, Denis Pezet, et al.. Long-Term Effects, Pathophysiological Mechanisms, and Risk Factors of Chemotherapy-Induced Peripheral Neuropathies: A Comprehensive Literature Review. Frontiers in Pharmacology, 2017, 8, ⟨10.3389/fphar.2017.00086⟩. ⟨hal-01682157⟩
- Accès au bibtex
- ref_biblio
- Nicolas Kerckhove, Bruno Pereira, Denis Pezet, David Balayssac. Clinical assessment of new antineuropathic strategies for chemotherapy-induced peripheral neuropathy: pain should not be the principal endpoint. Pain, 2017, 158 (1), pp.180-182. ⟨10.1097/j.pain.0000000000000743⟩. ⟨hal-01607744⟩
- Accès au bibtex
2016
- ref_biblio
- Bertrand Le Roy, Lucie Tixier, Bruno Pereira, Pierre Sauvanet, Emmanuel Buc, et al.. Assessment of the relation between the expression of oxaliplatin transporters in colorectal cancer and response to FOLFOX-4 adjuvant chemotherapy: A case control study. PLoS ONE, 2016, 11 (2), pp.1-12. ⟨10.1371/journal.pone.0148739⟩. ⟨hal-02635623⟩
- Accès au texte intégral et bibtex
Poster communications
2019
- ref_biblio
- David Balayssac. Prevention of oxaliplatin-induced peripheral neuropathy by a polyamine-reduced diet: preliminary results of animal and clinical studies. 7th International Congress on Neuropathic Pain (NeuPSIG 2019, May 2019, LONDRE, France. ⟨hal-02363909⟩
- Accès au bibtex